Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsia
about
Preeclampsia 2012Physiological changes in pregnancyThe renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?A Comprehensive Review of Hypertension in PregnancyAngiogenic factors in diagnosis, management, and research in preeclampsia.Hypertensive disorders in pregnancyRelaxin Treatment in an Ang-II-Based Transgenic Preeclamptic-Rat ModelBiocultural perspectives on maternal mortality and obstetrical death from the past to the presentOuabain inhibits placental sFlt1 production by repressing HSP27-dependent HIF-1α pathway.Angiogenic growth factors are new and essential players in the sustained relaxin vasodilatory pathway in rodents and humansRelaxin does not improve Angiotensin II-induced target-organ damage.Relaxin increases human endothelial progenitor cell NO and migration and vasculogenesis in miceWhy non-invasive maternal hemodynamics assessment is clinically relevant in early pregnancy: a literature reviewRelaxin mediates uterine artery compliance during pregnancy and increases uterine blood flow.GPCRs as potential therapeutic targets in preeclampsia.Relaxin increases sympathetic nerve activity and activates spinally projecting neurons in the paraventricular nucleus of nonpregnant, but not pregnant, rats.Relaxin treatment reverses insulin resistance in mice fed a high-fat dietRelaxin suppresses atrial fibrillation by reversing fibrosis and myocyte hypertrophy and increasing conduction velocity and sodium current in spontaneously hypertensive rat hearts.Adaptive regulation of endothelin receptor type-A and type-B in vascular smooth muscle cells during pregnancy in rats.Relaxin: new pathophysiological aspects and pharmacological perspectives for an old protein.New insights into combinational drug therapy to manage congestion in heart failure.Relaxin treatment reduces angiotensin II-induced vasoconstriction in pregnancy and protects against endothelial dysfunction†.Vascular actions of relaxin: nitric oxide and beyond.Serelaxin improves the pathophysiology of placental ischemia in the reduced uterine perfusion pressure rat model of preeclampsia.Animal models of preeclampsia: translational failings and why.Placental Nano-vesicles Target to Specific Organs and Modulate Vascular Tone In Vivo.Effects of serelaxin on renal microcirculation in rats under control and high-angiotensin environments.Human relaxins (RLNH1, RLNH2), their receptor (RXFP1) and fetoplacental growth.Physiology of blood pressure relevant to managing hypertension in pregnancy.Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.Topographic, tomographic and biomechanical corneal changes during pregnancy in patients with keratoconus: a cohort study.Altered Endothelial Nitric Oxide Signaling as a Paradigm for Maternal Vascular Maladaptation in Preeclampsia.Intranasally administered serelaxin abrogates airway remodelling and attenuates airway hyperresponsiveness in allergic airways disease.
P2860
Q21285024-305812BC-C5E7-408B-9D9F-7A81162C01F7Q26746794-66BEBF86-7CF3-4572-BD49-0366D9D996ECQ27003301-8B40A7B4-DED8-4E33-94F1-B3C30B4EA6D7Q27495953-8A340064-2AD8-4715-8B2B-38DBAEB2BB4FQ27692060-BF8F3D12-E948-486D-9A8D-224AE4B51E43Q28078452-675ADC7F-FACE-4788-AB34-926C71D21282Q28550653-65FDD567-EC66-48ED-A125-85186FE3E22BQ30051970-6514F6AB-5F80-47E9-8039-91A588F1A6A7Q34365552-ED0B4128-3FF4-4B8E-A1CD-CB2BB1A1C3C7Q35042471-A907079E-73DA-4B0D-A8C0-8E70E4FB6540Q35141812-1DE72E12-D660-435F-BD37-27AC0CBCDF57Q35669250-EA5B365A-BFE6-42BA-A962-314BCC014BCCQ36160792-CFE93C22-F9B3-423E-8E8C-CE397B8F31E2Q36252373-F9DECA2B-5BA3-43BE-B964-7D30F2D0C51BQ36380039-CD51D819-10A7-4806-A77A-B01476FA7B66Q36422548-FC9CAB8F-B50C-4663-862F-E67B893581C3Q37110579-93D9FF46-CF35-48B9-ABC8-F8776E0DE440Q37173939-26C2F246-F7DC-4BEA-ACBC-B8A595F06CBFQ37402307-244F6E74-471A-4D11-A187-57A42A0C0D2BQ38080804-CE49AF5A-A295-4D76-9B9D-2FD4EDCC8064Q38161844-A9CC2A50-784E-4BEA-B56B-9F795D4BB997Q38853366-B7CE3D9C-DCFE-4878-8B94-FCA42438F286Q38945156-9266252C-D326-492D-B7CC-E6D672A41330Q45350029-3B9FBB96-05D4-40A3-AD2D-079F2A14B505Q46300987-BF207B48-8691-4AAC-9575-BAF6C9C1591FQ47241206-3272624E-55DB-435E-AAB8-16DE1933DA58Q47619900-9FC63886-78E2-4A1C-AF04-62794C34057AQ47774900-2494F9A8-E04E-4097-8424-2E4F6FFA92EAQ47782453-D877382B-D60C-4652-87E6-6E42AF832F6CQ47883366-2DE322A8-F3C4-458D-A3AD-71DECCCC8D4AQ47967887-447E9F68-CF0C-41D5-BDF6-98FB3962E737Q49887672-A255E5A5-4B81-4BA9-A7D3-C16B4089E4EEQ51121563-DAA6B53E-DFB4-4495-A37A-4BF183BF1BFC
P2860
Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsia
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Emerging role of relaxin in th ...... implications for preeclampsia
@ast
Emerging role of relaxin in th ...... implications for preeclampsia
@en
type
label
Emerging role of relaxin in th ...... implications for preeclampsia
@ast
Emerging role of relaxin in th ...... implications for preeclampsia
@en
prefLabel
Emerging role of relaxin in th ...... implications for preeclampsia
@ast
Emerging role of relaxin in th ...... implications for preeclampsia
@en
P2860
P1476
Emerging role of relaxin in th ...... implications for preeclampsia
@en
P2093
Kirk P Conrad
P2860
P356
10.1016/J.SEMNEPHROL.2010.10.003
P577
2011-01-01T00:00:00Z